PHARMA
NeoStem & CBMG Embark On Phase II Trial For Liver Cancer
The Phase II trial for patients with late stage liver cancer will examine the effectiveness of a dendritic cell-based therapy.
ASLAN & CSL To Develop Asthma Treatment
ASLAN acquires license for CSL334, an anti-IL13 receptor monoclonal antibody for the treatment of asthma.
WuXi Completes Biosafety Facility In Suzhou
Continuing with its rapid expansion of manufacturing capabilities, WuXi completes a new 38,000 square foot facility in Suzhou.
Biocon’s Mazumdar-Shaw Honored By Chemical Heritage Foundation
Kiran Mazumdar-Shaw, founder of the Bangalore-based biotech company Biocon, is the first Indian to be awarded the Othmer Gold Medal.
Novartis Launches Blood Cancer Drug, Jakavi®
Jakavi, the only approved oral medication for the blood cancer myelofibrosis, has been introduced in Singapore and 50 other countries.
Tianjin & AstraZeneca Collaborate On Cardiovascular Disease
Tianjin Medical University and Astrazeneca will collaborate to develop soluble epoxide hydrolase inhibitors for the treatment of cardiac fibrosis.
Tigermed Buys Majority Stake In Frontage For US$50 Million
Tigermed's acquires Frontage to leverage their expertise in preclinical and early clinical development.
Shire Acquires Fibrotech For US$75 Million
Shire's acquisition of the University of Melbourne-affiliated Fibrotech highlights the potential for commercialization in public-private partnerships.
Agilent & SNU To Launch Drug Development Center
Agilent Technologies collaborates with the Seoul National University on a new drug development center to be housed in the university's college of pharmacy.
